Insights

Boosting Sales Force Effectiveness in Medtech

Tobi Laczkowski and Eric Scott


 


> Download

The medical products and services industry has an established history of investing in sales force effectiveness (SFE), typically to boost the productivity of companies’ highly experienced field reps, yet some firms struggle to gauge the performance of those investments. Firms may have trouble determining accurate competitor benchmarks because of the medical technology industry’s expansive breadth, with products ranging from basic supplies to highly sophisticated medical technology (with correspondingly different business models). Moreover, SFE encompasses different types of initiatives and different levels of ambition—from small, continuous-improvement activities to more comprehensive transformations—which adds to the challenge of determining a target return on investment.

This is a clear challenge: Sales leaders in medtech know that SFE investments pay off through incremental revenue and profits, but they don’t have clear benchmarks to indicate what success looks like.

To better understand the impact of SFE investments, ZS Associates recently conducted the Explorer Study, a rigorous, cross-industry analysis of more than 800 data points from a wide range of survey respondents; literature sources including academic journals, white papers, trade publications and other business media; interviews with industry leaders; and internal ZS case studies, searching for data on quantifiable gains in performance following SFE investments. The study found that investments in a single sales force initiative can yield an average increase in revenue of 4 to 8% across all industries. For the subset of medtech companies in the sample, SFE investments lead to increases in revenue and profitability of 2 to 8%, meaning that such programs often can pay for themselves, and larger transformative initiatives across several SFE areas can generate even greater impact.

Download the article for more insights.

About the Experts




Tobi Laczkowski is a principal in ZS Associates’ Evanston, Ill., office and was previously based in the Zurich office. He has worked primarily with medical products clients in numerous practice areas, including sales force effectiveness, go-to-market strategy and transformation, compensation design, value proposition design and recruiting effectiveness. Tobi has worked on projects in North and South America, Europe and Asia.




Eric Scott is a manager based in ZS’s Toronto office. Eric focuses on broad sales and marketing issues across Canada and the Americas. Eric is a member of ZS’s talent management practice area, and also is a leader in medical affairs strategy and commercial organizational design. He has helped many clients with maximizing go-to-market strategies through market insight and sales strategy, forecasting and opportunity assessments, sales operations and incentives, and broad business technology solutions.